125 mg töflur. clinical trials

Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK)

This study, called DANBLOCK, is looking into whether common heart medications called beta-blockers help people who have had a heart attack but whose heart is still pumping well. It aims to see if these medications can prevent future heart problems and improve overall health.